This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Pignatello, R.; Simerska, P.; Leonardi, A.; Abdelrahim, A.S; Petronio, G.P.; Fuochi, V.; Furneri, P.M.; Ruozi B.; Toth I. Synthesis, characterization and in vitro evaluation of amphiphilic ion pairs of erythromycin and kanamycin antibiotics with liposaccharides. Eur J Med Chem., 2016, 120,329–337.PignatelloR.SimerskaP.LeonardiA.AbdelrahimA.S.PetronioG.P.FuochiV.FurneriP.M.RuoziB.TothI.Synthesis, characterization and in vitro evaluation of amphiphilic ion pairs of erythromycin and kanamycin antibiotics with liposaccharides201612032933710.1016/j.ejmech.2016.04.074Search in Google Scholar
Baasov, T.; Atia-Glikin, D.; Kandasamy, J.; Belakhov, V. Technion Research and Development Foundation Ltd, 2015. Aminoglycosides and uses thereof in treating genetic disorders. U.S. Patent 9,175,029.BaasovT.Atia-GlikinD.KandasamyJ.BelakhovV.Technion Research and Development Foundation Ltd2015U.S. Patent 9,175,029.Search in Google Scholar
Ito, Y.; Kusawake, T.; Ishida, M.; Tawa, R.; Shibata, N.; Takada, K. Oral solid gentamicin preparation using emulsifier and adsorbent. J Controlled Release, 2005,105(1–2),23–31.ItoY.KusawakeT.IshidaM.TawaR.ShibataN.TakadaK.Oral solid gentamicin preparation using emulsifier and adsorbent20051051–2233110.1016/j.jconrel.2005.03.017Search in Google Scholar
Imamura, S.; Adams, J.C. Distribution of gentamicin in the guinea pig inner ear after local or systemic application. JARO, 2003, 04, 176–195.ImamuraS.AdamsJ.C.Distribution of gentamicin in the guinea pig inner ear after local or systemic application20030417619510.1007/s10162-002-2036-8Search in Google Scholar
Labiris, N.R.C.; Holbrook, A.M.; Chrystyn, H.; Macleod, S.M.; Newhouse, M.T. Dry powder versus intravenous and nebulized gentamicin in cystic Fibrosis and bronchiectasis; a pilot study. Am J Respir Crit Care Med 1999, 160(5), 1711–1716.LabirisN.R.C.HolbrookA.M.ChrystynH.MacleodS.M.NewhouseM.T.Dry powder versus intravenous and nebulized gentamicin in cystic Fibrosis and bronchiectasis; a pilot study199916051711171610.1164/ajrccm.160.5.9810080Search in Google Scholar
Ipsen, T.; Jørgensen, P.S.; Damholt, V.; Tørholm, C. Gentamicin-collagen sponge for local applications: 10 cases of chronic osteomyelitis followed for 1 year. Acta OrthopScand., 1991, 62(6), 592–594.IpsenT.JørgensenP.S.DamholtV.TørholmC.Gentamicin-collagen sponge for local applications: 10 cases of chronic osteomyelitis followed for 1 year199162659259410.3109/17453679108994503Search in Google Scholar
Nnamani, P.O.; Kenechukwu, F.C.; Dibua, E.U.; Ogbonna, C.C.; Momoh, M.A.; 1, Olisemeka, A.U.; Obumneme, A.C.; Attama, A.A. Formulation, characterization and ex-vivo permeation studies on gentamicin-loaded transdermal patches based on PURASORB® polymers Sci Res Essays. 2013, 8(22), 973–982NnamaniP.O.KenechukwuF.C.DibuaE.U.OgbonnaC.C.MomohM.A.OlisemekaA.U.ObumnemeA.C.AttamaA.A.Formulation, characterization and ex-vivo permeation studies on gentamicin-loaded transdermal patches based on PURASORB® polymers2013822973982Search in Google Scholar
Pick, J.; Olson, L.L.; Ellis, W.Y.; Lim, P. Development and validation of a method to extract and quantitate paromomycin and gentamicin from an aquaphilic cream formulation. J Pharm Biomed Anal., 1997; 16, 131–137.PickJ.OlsonL.L.EllisW.Y.LimP.Development and validation of a method to extract and quantitate paromomycin and gentamicin from an aquaphilic cream formulation19971613113710.1016/S0731-7085(96)02044-4Search in Google Scholar
Ravis, W.R.; Llanos-Cuentas, A.; Sosa, N. Kreishman-Deitrick, M.; Kopydlowski, K.M.; Nielsen, C.; Smith, K.S.; Smith, P.L.; Ransom, J.H.; Lin Y-J.; Grogl M. Pharmacokinetics and absorption of paromomycin and gentamicin from topical creams used to treat cutaneous leishmaniasis. Antimicrob. Agents Chemother. 2013, 57(10), 4809–4815.RavisW.R.Llanos-CuentasA.SosaN.Kreishman-DeitrickM.KopydlowskiK.M.NielsenC.SmithK.S.SmithP.L.RansomJ.H.LinY-J.GroglM.Pharmacokinetics and absorption of paromomycin and gentamicin from topical creams used to treat cutaneous leishmaniasis201357104809481510.1128/AAC.00628-13Search in Google Scholar
Aquino, R.P.; Prota, L.; Auriemma, G.; Santoro, A.; Mencherini, T.; Colombo, G.; Russo, P. Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells. Int J Pharm., 2012, 426, 100–107.AquinoR.P.ProtaL.AuriemmaG.SantoroA.MencheriniT.ColomboG.RussoP.Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells201242610010710.1016/j.ijpharm.2012.01.026Search in Google Scholar
Goldman, J.M., Bayston, S.M.; O’Connor, S., Meigh, R.E. Inhaled micronised gentamicin powder: a new delivery system. Thorax., 1990; 45:939–940.GoldmanJ.M.BaystonS.M.O’ConnorS.MeighR.E.Inhaled micronised gentamicin powder: a new delivery system19904593994010.1136/thx.45.12.939Search in Google Scholar
Lim, S.T.; Forbes, B.; Berry, D.J.; Martin, G.P.; Brown, M.B. In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits. Int J Pharm. 2002, 231:73–82.LimS.T.ForbesB.BerryD.J.MartinG.P.BrownM.B.In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits2002231738210.1016/S0378-5173(01)00873-0Search in Google Scholar
Fix, J.A.; Porter, P.A.; Leppert, P.S. Involvement of active sodium transport in the rectal absorption of gentamicin sulfate in the presence and absence of absorption-promoting adjuvants. J Pharm Sci., 1983, 72(6), 698–700.FixJ.A.PorterP.A.LeppertP.S.Involvement of active sodium transport in the rectal absorption of gentamicin sulfate in the presence and absence of absorption-promoting adjuvants198372669870010.1002/jps.2600720626Search in Google Scholar
Krasko, M.Y.; Golenser, J.; Nyska, A.; Nyska, M., Brin, Y.S.; Domb, A.J. Gentamicin extended release from an injectable polymeric implant. J Control Release. 2007; 117:90–96.KraskoM.Y.GolenserJ.NyskaA.NyskaM.BrinY.S.DombA.J.Gentamicin extended release from an injectable polymeric implant2007117909610.1016/j.jconrel.2006.10.010Search in Google Scholar
Soriano, I.; Evora, C. Formulation of calcium phosphates/poly (d, l-lactide) blends containing gentamicin for bone implantation. J Controlled Release, 2000, 68, 121–134.SorianoI.EvoraC.Formulation of calcium phosphates/poly (d, l-lactide) blends containing gentamicin for bone implantation20006812113410.1016/S0168-3659(00)00251-0Search in Google Scholar
Rama Prasad, Y.V.; Eaimtrakarn, S.; Ishida, M.; Kusawake, Y.; Tawa, R.; Yoshikawa, Y.; Shibata, N.; Takada, K. Evaluation of oral formulations of gentamicin containing labrasol in beagle dogs. Inter J Pharmaceut., 2003, 268, 13–21.Rama PrasadY.V.EaimtrakarnS.IshidaM.KusawakeY.TawaR.YoshikawaY.ShibataN.TakadaK.Evaluation of oral formulations of gentamicin containing labrasol in beagle dogs2003268132110.1016/j.ijpharm.2003.08.00814643972Search in Google Scholar
Gephart, SM., McGrath, JM., Effken, JA. and Halpern, MD. (2012). Necrotizing Enterocolitis Risk. Adv Neonatal Care, 12(2): 77–89. doi: 10.1097/ANC.0b013e31824cee94GephartSM.McGrathJM.EffkenJA.HalpernMD.2012Necrotizing Enterocolitis Risk122778910.1097/ANC.0b013e31824cee94335763022469959Open DOISearch in Google Scholar
Shah D and Sinn JK. (2012). Antibiotic regimens for the empirical treatment of newborn infants with necrotising enterocolitis. Cochrane Database Syst Rev. 15; 8:CD007448. doi: 10.1002/14651858.CD007448.pub2.ShahDSinnJK2012Antibiotic regimens for the empirical treatment of newborn infants with necrotising enterocolitis158CD007448.10.1002/14651858.CD007448.pub222895960Open DOISearch in Google Scholar
Verma, K., Gupta, A.B. and Singh, A., (2014). Optimization of Chlorination Process and Analysis of. Water Sci, 4(3), 231–239.VermaK.GuptaA.B.SinghA.2014Optimization of Chlorination Process and Analysis of43231239Search in Google Scholar
Anilkumar, P.; Badarinath, A.V.; Naveen, N.; Nirosha, M. A rationalized description on study of intestinal barrier, drug permeability and permeation enhancers. J Global Trends Pharma Sci., 2011, 2(4), 431–449.AnilkumarP.BadarinathA.V.NaveenN.NiroshaM.A rationalized description on study of intestinal barrier, drug permeability and permeation enhancers201124431449Search in Google Scholar
Shaikh, M.S.; Derle, N.D.; Bhamber, R. Permeability enhancement techniques for poorly permeable drugs: a review. JAPS 2012, 02(06), 34–39.ShaikhM.S.DerleN.D.BhamberR.Permeability enhancement techniques for poorly permeable drugs: a review20120206343910.7324/JAPS.2012.2705Search in Google Scholar
Umeyor, C.; Attama, A.; Uronnachi, E.; Kenechukwu, F.; Nwakile, C.; Nzekwe, I.; Okoye, E.; Esimone, C. Formulation design and in vitro physicochemical characterization of surface modified self-nanoemulsifying formulations (SNEFs) of gentamicin. Inter J Pharmaceut 2016; 497:161–98.UmeyorC.AttamaA.UronnachiE.KenechukwuF.NwakileC.NzekweI.OkoyeE.EsimoneC.Formulation design and in vitro physicochemical characterization of surface modified self-nanoemulsifying formulations (SNEFs) of gentamicin20164971619810.1016/j.ijpharm.2015.10.03326657350Search in Google Scholar
Walker, M.M.; Talley, N.J. Review article: bacteria and pathogenesis of disease in the upper gastrointestinal tract – beyond the era of Helicobacter pylori. Aliment Pharm Ther., 2014; 39(8), 767–779.WalkerM.M.TalleyN.J.Review article: bacteria and pathogenesis of disease in the upper gastrointestinal tract – beyond the era of Helicobacter pylori201439876777910.1111/apt.1266624612362Search in Google Scholar
Nwakile, C.D. Production, Characterization and Application of Multiple Modified Maize Starches in the Formulation of Oral Solid Dosage Forms of Gentamicin Sulphate. A thesis submitted to the Department of Pharmaceutics in partial fulfilment for the award of doctor of philosophy (Ph.D) of the University of Nigeria, Nsukka, Enugu State, Nigeria. 2017. Available at: http://dspace.unn.edu.ng/bitstream/handle/123456789/5494/Nwakile%2C%20Calistus%20Dozie.pdf?sequence=1&isAllowed=y, Accessed February 20, 2020.NwakileC.D.A thesis submitted to the Department of Pharmaceutics in partial fulfilment for the award of doctor of philosophy (Ph.D) of the University of NigeriaNsukka, Enugu State, Nigeria2017Available at: http://dspace.unn.edu.ng/bitstream/handle/123456789/5494/Nwakile%2C%20Calistus%20Dozie.pdf?sequence=1&isAllowed=y, Accessed February 20, 2020.Search in Google Scholar
Canadian Pharmaceutical Association Compendium of Pharmaceuticals and Specialities, the Canadian drug reference for health professionals. Webcom limited, Toronto, 2002.Webcom limitedToronto2002Search in Google Scholar
EMEA. Gentamicin: Summary report (3) - Committee for Veterinary Medicinal Products EMEA/MRL/803/01-final November 2001. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_Report/2009/11/WC500014350.pdf.. Accessed March 2, 2020.EMEAAvailable at: http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_Report/2009/11/WC500014350.pdf.. Accessed March 2, 2020.Search in Google Scholar
Kibbe AH. Hand book of Pharmaceutical excipients, 3rd ed. Washington: American Pharmaceutical Association and Pharmaceutical Press; 2000.KibbeAH3rd ed.WashingtonAmerican Pharmaceutical Association and Pharmaceutical Press2000Search in Google Scholar